Observational studyJournal of cancer research and clinical oncology2024

Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real world data of a multicenter study.

Axel Hegele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.